A Game-Changer in Mesothelioma Therapy: Targeting YB-1 Protein
|

A Game-Changer in Mesothelioma Therapy: Targeting YB-1 Protein

An international team of researchers has discovered a unique YB-1 protein. It can make chemotherapy more effective at treating mesothelioma. Combating Mesothelioma with Precision Mesothelioma is an aggressive type of cancer, especially when it affects the lining around our lungs. It is caused by exposure to asbestos. Finding effective treatments has been a challenge, but recent research has brought a ray of hope. Scientists have been studying a particular protein called Y-box-binding protein 1 (YB-1). It plays a vital role in the growth and movement of mesothelioma cells. When treating mesothelioma, one of the main approaches is chemotherapy. This powerful treatment uses drugs to target and kill cancer cells. The only FDA-approved chemotherapy drug combination is pemetrexed with cisplatin. Sometimes,…

How Inflammation, Stress, and Signaling Shape Mesothelioma’s Growth
| |

How Inflammation, Stress, and Signaling Shape Mesothelioma’s Growth

Scientists are looking at how long-term inflammation, cell stress, and messed-up cell signaling help mesothelioma cancer cells grow and spread. By looking at these processes in mesothelioma patients, the scientists can learn more about new ways to treat this aggressive cancer. Revolutionizing Mesothelioma Treatment Malignant mesothelioma is a type of cancer that develops from the thin layer of tissue that covers many of the body’s internal organs. When it grows in the lining of the lungs, it is called pleural mesothelioma. There are about 2,000 cases of pleural mesothelioma in the United States each year. Mesothelioma is linked to exposure to a toxic mineral called asbestos. It can take decades for symptoms of mesothelioma to appear after a person is…

How Photodynamic Therapy is Changing the Game for Mesothelioma Patients
|

How Photodynamic Therapy is Changing the Game for Mesothelioma Patients

When it comes to treating a tough cancer like malignant pleural mesothelioma, doctors use many different methods. One important way is surgery to remove the big parts of the disease. Researchers from the University of Pennsylvania have been studying how another treatment called photodynamic therapy (PDT) can help during surgery. PDT is a special light treatment has shown potential in animal studies. Surgery and PDT can work together to help mesothelioma patients. Combining Surgery and PDT for Optimal Treatment Mesothelioma is a rare but deadly cancer caused by asbestos exposure. Pleural mesothelioma occurs on the membrane around the lungs. It is the most common type of mesothelioma. Around 2,500 Americans receive a mesothelioma diagnosis each year. There is no cure. Surgery plays…

Breaking Down Mesothelioma: Diagnosis and Treatment Options
| | |

Breaking Down Mesothelioma: Diagnosis and Treatment Options

An international team of scientists from India, Malaysia, and Indonesia published an overview of the diagnosis and treatment of mesothelioma. Their report was published in the scientific journal Frontiers in Oncology. Understanding Mesothelioma Diagnosis and Treatment Mesothelioma is a rare and aggressive tumor that grows in the lining of certain body cavities. It usually happens in the chest, abdomen, or around the heart. Mesothelioma is caused by exposure to asbestos, a harmful substance that was once used in many industries. Even though asbestos is now banned in many places, the number of mesothelioma cases is still increasing. Diagnosing mesothelioma is challenging because it can look like more common diseases. To diagnose mesothelioma, doctors often use imaging tests like X-rays, CT…

Exploring Cutting-Edge Treatments for Pleural Mesothelioma
| |

Exploring Cutting-Edge Treatments for Pleural Mesothelioma

A new study looks at the current treatments available for people with mesothelioma. The authors of this overview are based in Italy at the University of Bologna. Advancements in Mesothelioma Treatment Malignant mesothelioma is a type of cancer that develops from the thin layer of tissue that covers internal organs. When mesothelioma grows in the lungs, it is called pleural mesothelioma. This aggressive cancer is caused by exposure to asbestos. Asbestos is a toxic mineral found in nature. It can be used in manufacturing and construction materials and is illegal in many countries. Mesothelioma is a very rare cancer, and the symptoms can be like many other diseases. This makes it hard for doctors to make a diagnosis. For mesothelioma…

Mesothelioma Care: Why Academic Centers Hold the Key to Improved Survival
| |

Mesothelioma Care: Why Academic Centers Hold the Key to Improved Survival

Researchers from the Mayo Clinic found out that people with mesothelioma who were treated at academic centers had a better chance of living longer than those treated at community centers. They shared their discoveries at the annual meeting of the American Society of Clinical Oncology. Mesothelioma is a type of cancer that is tough to treat, and there aren’t many options for therapy. It happens when someone is exposed to a harmful mineral called asbestos. Surgery, chemotherapy, and radiation therapy are common treatments. The Difference Between Academic and Community Centers Medical centers with expert doctors and more resources are called academic centers. They often see more cases of rare cancers like mesothelioma. But until now, we didn’t know if getting…

Promising Results of CRS/HIPEC Treatment
| | |

Promising Results of CRS/HIPEC Treatment

A new treatment can lead to good short- and long-term outcomes for patients with mesothelioma. It’s called cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS/HIPEC). Research results came from the Medical University of Vienna in Austria. They looked at the first 100 mesothelioma patients who had this treatment in their hospital. Advancing Mesothelioma Care Mesothelioma is a rare form of cancer that grows in the lining that covers many of the internal organs of the body. Mesothelioma is caused by exposure to asbestos. There are approximately 2,000 cases of mesothelioma diagnosed in the United States every year. The standard treatment for mesothelioma usually includes surgery, chemotherapy, and radiation. The typical prognosis with standard treatment is survival between one and five years….

Identifying Mesothelioma: How Extracellular Vesicles Could Be the Key
|

Identifying Mesothelioma: How Extracellular Vesicles Could Be the Key

Scientists believe that particles called extracellular vesicles could be used as biomarkers to identify malignant pleural mesothelioma (MPM). Malignant pleural mesothelioma is an aggressive and deadly cancer that affects the lining of the lungs and chest cavity. It is caused by exposure to asbestos, usually at work. It has a low survival rate, so it is important to find ways to diagnose it early. It is also important for doctors to be able to predict how it will develop in patients. How Mesothelioma is Diagnosed Mesothelioma is usually diagnosed after a person goes to a doctor because they are experiencing symptoms. For MPM, a person might feel shortness of breath due to fluid around the lung, chest pain, cough, and…

Treatment Combination Used Most for Mesothelioma
| |

Treatment Combination Used Most for Mesothelioma

Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) is being used by doctors to treat malignant peritoneal mesothelioma (MPM) more often. This is the finding of a study published in the Annals of Surgical Oncology. This is promising news because research has shown the CRS-HIPEC can be an effective treatment for patients with MPM. Mesothelioma Caused by Asbestos Exposure MPM is caused by exposure to a toxic material called asbestos. Most doctors believe it is caused from ingestion of asbestos fibers and that microscopic asbestos fibers become embedded in the abdomen. After about 20-50 years, these fibers can cause inflammation and mutations that ultimately caused tumors to form. This cancer occurs in less than 1,000 people in the United States…

Bortezomib Shows Promise as New Mesothelioma Treatment
|

Bortezomib Shows Promise as New Mesothelioma Treatment

A drug called Bortezomib can help treat malignant mesothelioma when given directly into the area affected by the cancer. This interesting finding comes from a team of scientists from Italy. They tested Bortexomib on mesothelioma cells to find out if it can stop cancer cell growth. New Research for New Treatments Malignant mesothelioma is a rare cancer caused by asbestos exposure. It develops from the thin layer of tissue that covers many of the body’s internal organs, like the lungs and abdominal cavity. The treatment options for malignant mesothelioma are limited. Conventional treatments for mesothelioma consist of chemotherapy, surgery, and sometimes radiation therapy. Even with treatment, the prognosis for mesothelioma is not good. The median survival rate of patients with…